Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers


1. 1,2 Dimyristoyl Glycero 3 Phosphorylcholine
2. 1,2 Ditetradecanoyl Glycero 3 Phosphocholine
3. 1,2 Ditetradecyl Glycero 3 Phosphocholine
4. 1,2-dimyristoyl-glycero-3-phosphorylcholine
5. 1,2-ditetradecanoyl-glycero-3-phosphocholine
6. 1,2-ditetradecyl-glycero-3-phosphocholine
7. Dimyristoyllecithin
8. Dimyristoylphosphatidylcholine
9. Dmcp
10. Dmpc
1. 1,2-dimyristoyl-rac-glycero-3-phosphocholine
2. 18656-38-7
3. Dl-dimyristoylphosphatidylcholine
4. 13699-48-4
5. Dmpc
6. 2,3-di(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl Phosphate
7. Dl-beta,gamma-dimyristoyl-alpha-lecithin
8. Dimyristoyl-phosphatidylcholine
9. U86zgc74v5
10. Chebi:241349
11. Dimyristoyllecithin
12. L-alpha-dimyristoylphosphatidylcholine
13. Ncgc00181029-01
14. (1)-(7-myristoyl-4-oxido-10-oxo-3,5,9-trioxa-4-phosphatricosyl)trimethylammonium 4-oxide
15. 3,5,9-trioxa-4-phosphatricosan-1-aminium, 4-hydroxy-n,n,n-trimethyl-10-oxo-7-((1-oxotetradecyl)oxy)-, Inner Salt, 4-oxide
16. Unii-u86zgc74v5
17. Einecs 242-481-1
18. Soy Bean Phospholipid
19. Dsstox_cid_26816
20. Dsstox_rid_81928
21. 1,2-ditetradecanoyl-rac-glycerol-3-phosphocholine
22. Dsstox_gsid_46816
23. Schembl244839
24. Chembl316257
25. Dtxsid4046816
26. Dimyristoyl-.alpha.-lecithin
27. Tox21_112679
28. Mfcd00066562
29. Akos024418777
30. Db11283
31. Hy-w142596
32. 1,2-dimyristoyl-phosphatidylcholine
33. Cas-18656-38-7
34. Cs-0204636
35. Ft-0625421
36. Ft-0627667
37. Ft-0627775
38. 1,2-dimyristoyl-dl-phosphatidylcholine
39. D-5665
40. D-5667
41. Dimyristoyl Phosphatidylcholine, (+/-)
42. 1,2-dimyristoyl-glycero-3-phosphocholine
43. A839808
44. 1,2-dimyristoyl-phosphatidylcholine, (+/-)
45. 1,2-dimyristoyl-glycero-3-phosphocholine, Dl-
46. 1,2-dimyristoyl-rac-glycero-3-phosphocholine, >=99%
47. Q27225712
48. 1,2-dimyristoyl-glycero-3-phosphocholine, (+/-)-
49. 2,3-bis(1-oxotetradecoxy)propyl 2-(trimethylammonio)ethyl Phosphate
50. 2,3-bis(tetradecanoyloxy)propyl 2-(trimethylammonio)ethyl Phosphate
51. 2,3-bis(tetradecanoyloxy)propyl 2-(trimethylazaniumyl)ethyl Phosphate
52. [2-({[2,3-bis(tetradecanoyloxy)propyl] Phosphonato}oxy)ethyl]trimethylazanium
53. 3,5,9-trioxa-4-phosphatricosan-1-aminium,4-hydroxy-n,n,n-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-, Inner Salt, 4-oxide
54. 3,5,9-trioxa-4-phosphatricosan-1-aminium,4-hydroxy-n,n,n-trimethyl-10-oxo-7-[(1-oxotetradecyl)oxy]-,inner Salt,4-oxide
| Molecular Weight | 677.9 g/mol |
|---|---|
| Molecular Formula | C36H72NO8P |
| XLogP3 | 11.3 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 36 |
| Exact Mass | 677.49955525 g/mol |
| Monoisotopic Mass | 677.49955525 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 46 |
| Formal Charge | 0 |
| Complexity | 765 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 1 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
DL-dimyristoylphosphatidylcholine is not an active pharmaceutical agent and has no indication.
DL-dimyristoylphosphatidylcholine is a water soluble phospholipid used to solubilize drugs for injection.
Indicators and Reagents
Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant and Hackh's Chemical Dictionary, 5th ed, p301, p499) (See all compounds classified as Indicators and Reagents.)
As a phospholipid, DL-dimyristoylphosphatidylcholine can form a micelle with a hydrophobic core to contain lipophilic drugs while maintaining a hyrophilic outer portion to allow increased solubility of the drug in the aqueous environment of the blood or gastrointestinal tract.
Market Place
ABOUT THIS PAGE
97
PharmaCompass offers a list of Dimyristoyl Lecithin API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Dimyristoyl Lecithin manufacturer or Dimyristoyl Lecithin supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Dimyristoyl Lecithin manufacturer or Dimyristoyl Lecithin supplier.
PharmaCompass also assists you with knowing the Dimyristoyl Lecithin API Price utilized in the formulation of products. Dimyristoyl Lecithin API Price is not always fixed or binding as the Dimyristoyl Lecithin Price is obtained through a variety of data sources. The Dimyristoyl Lecithin Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A D-5665 manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of D-5665, including repackagers and relabelers. The FDA regulates D-5665 manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. D-5665 API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A D-5665 supplier is an individual or a company that provides D-5665 active pharmaceutical ingredient (API) or D-5665 finished formulations upon request. The D-5665 suppliers may include D-5665 API manufacturers, exporters, distributors and traders.
click here to find a list of D-5665 suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A D-5665 DMF (Drug Master File) is a document detailing the whole manufacturing process of D-5665 active pharmaceutical ingredient (API) in detail. Different forms of D-5665 DMFs exist exist since differing nations have different regulations, such as D-5665 USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A D-5665 DMF submitted to regulatory agencies in the US is known as a USDMF. D-5665 USDMF includes data on D-5665's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The D-5665 USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of D-5665 suppliers with USDMF on PharmaCompass.
D-5665 Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of D-5665 GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right D-5665 GMP manufacturer or D-5665 GMP API supplier for your needs.
A D-5665 CoA (Certificate of Analysis) is a formal document that attests to D-5665's compliance with D-5665 specifications and serves as a tool for batch-level quality control.
D-5665 CoA mostly includes findings from lab analyses of a specific batch. For each D-5665 CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
D-5665 may be tested according to a variety of international standards, such as European Pharmacopoeia (D-5665 EP), D-5665 JP (Japanese Pharmacopeia) and the US Pharmacopoeia (D-5665 USP).